1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo International PLC, Sells Biogen Inc, Celgene Corp, Allergan PLC

New York, NY, based Investment company Orbimed Advisors Llc buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries, Endo International PLC, Edwards Lifesciences Corp, MeiraGTx Holdings PLC, Bristol-Myers Squibb Company, MyoKardia Inc, Prothena Corp PLC, Apellis Pharmaceuticals Inc, Deciphera Pharmaceuticals Inc, CareDx Inc, Mylan NV, CymaBay Therapeutics Inc, Enanta Pharmaceuticals Inc, Intuitive Surgical Inc, Aurinia Pharmaceuticals Inc, Takeda Pharmaceutical Co, Abbott Laboratories, Mersana Therapeutics Inc, Natera Inc, ProQR Therapeutics NV, Amarin Corp PLC, Adverum Biotechnologies Inc, Spero Therapeutics Inc, Menlo Therapeutics Inc, Selecta Biosciences Inc, Amicus Therapeutics Inc, KalVista Pharmaceuticals Inc, Krystal Biotech Inc, sells Biogen Inc, Celgene Corp, Allergan PLC, CVS Health Corp, Centene Corp, UnitedHealth Group Inc, Cigna Corp, bluebird bio Inc, Molina Healthcare Inc, Ironwood Pharmaceuticals Inc, Aerie Pharmaceuticals Inc, argenx SE, DaVita Inc, Pfizer Inc, Spectrum Pharmaceuticals Inc, Puma Biotechnology Inc, AC Immune SA, Stryker Corp, Tandem Diabetes Care Inc, Tenet Healthcare Corp, HCA Healthcare Inc, Allakos Inc, Heron Therapeutics Inc, Zai Lab, Dermira Inc, Invitae Corp, Intercept Pharmaceuticals Inc, Sage Therapeutics Inc, electroCore Inc, Ra Medical Systems Inc, Avrobio Inc, Affimed NV, The Medicines Co, Redhill Biopharma, Recro Pharma Inc, Marinus Pharmaceuticals Inc, Sierra Oncology Inc, Alimera Sciences Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Orbimed Advisors Llc. As of 2019Q1, Orbimed Advisors Llc owns 116 stocks with a total value of $5.9 billion. These are the details of the buys and sells.

For the details of ORBIMED ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/orbimed+advisors+llc/current-portfolio/portfolio

These are the top 5 holdings of ORBIMED ADVISORS LLC
  1. Ascendis Pharma A/S (ASND) - 3,970,673 shares, 7.90% of the total portfolio. Shares reduced by 2.86%
  2. Tricida Inc (TCDA) - 10,889,280 shares, 7.11% of the total portfolio.
  3. Clementia Pharmaceuticals Inc (CMTA) - 10,425,225 shares, 4.60% of the total portfolio.
  4. Alexion Pharmaceuticals Inc (ALXN) - 1,957,200 shares, 4.47% of the total portfolio. Shares reduced by 4.41%
  5. Boston Scientific Corp (BSX) - 5,790,400 shares, 3.76% of the total portfolio.
New Purchase: Teva Pharmaceutical Industries Ltd (TEVA)

Orbimed Advisors Llc initiated holding in Teva Pharmaceutical Industries Ltd. The purchase prices were between $15.42 and $20.01, with an estimated average price of $17.62. The stock is now traded at around $11.50. The impact to a portfolio due to this purchase was 1.08%. The holding were 4,079,000 shares as of .

New Purchase: Endo International PLC (ENDP)

Orbimed Advisors Llc initiated holding in Endo International PLC. The purchase prices were between $7.3 and $11.24, with an estimated average price of $9.39. The stock is now traded at around $6.74. The impact to a portfolio due to this purchase was 0.84%. The holding were 6,165,464 shares as of .

New Purchase: Prothena Corp PLC (PRTA)

Orbimed Advisors Llc initiated holding in Prothena Corp PLC. The purchase prices were between $10.3 and $14.49, with an estimated average price of $12.45. The stock is now traded at around $9.95. The impact to a portfolio due to this purchase was 0.5%. The holding were 2,435,278 shares as of .

New Purchase: CareDx Inc (CDNA)

Orbimed Advisors Llc initiated holding in CareDx Inc. The purchase prices were between $22.09 and $39.21, with an estimated average price of $28.96. The stock is now traded at around $34.81. The impact to a portfolio due to this purchase was 0.44%. The holding were 827,600 shares as of .

New Purchase: CymaBay Therapeutics Inc (CBAY)

Orbimed Advisors Llc initiated holding in CymaBay Therapeutics Inc. The purchase prices were between $7.87 and $13.42, with an estimated average price of $10.56. The stock is now traded at around $13.20. The impact to a portfolio due to this purchase was 0.42%. The holding were 1,874,955 shares as of .

New Purchase: Enanta Pharmaceuticals Inc (ENTA)

Orbimed Advisors Llc initiated holding in Enanta Pharmaceuticals Inc. The purchase prices were between $69.08 and $105.66, with an estimated average price of $89.42. The stock is now traded at around $93.97. The impact to a portfolio due to this purchase was 0.38%. The holding were 233,100 shares as of .

Added: Neurocrine Biosciences Inc (NBIX)

Orbimed Advisors Llc added to a holding in Neurocrine Biosciences Inc by 270.94%. The purchase prices were between $69.31 and $91.53, with an estimated average price of $83.53. The stock is now traded at around $80.50. The impact to a portfolio due to this purchase was 1.99%. The holding were 1,833,200 shares as of .

Added: Edwards Lifesciences Corp (EW)

Orbimed Advisors Llc added to a holding in Edwards Lifesciences Corp by 53.57%. The purchase prices were between $143.66 and $192.15, with an estimated average price of $170.98. The stock is now traded at around $178.03. The impact to a portfolio due to this purchase was 0.81%. The holding were 715,000 shares as of .

Added: MeiraGTx Holdings PLC (MGTX)

Orbimed Advisors Llc added to a holding in MeiraGTx Holdings PLC by 423.51%. The purchase prices were between $9.2 and $21.21, with an estimated average price of $13.93. The stock is now traded at around $23.01. The impact to a portfolio due to this purchase was 0.58%. The holding were 2,460,251 shares as of .

Added: Bristol-Myers Squibb Company (BMY)

Orbimed Advisors Llc added to a holding in Bristol-Myers Squibb Company by 136.21%. The purchase prices were between $45.12 and $53.8, with an estimated average price of $49.88. The stock is now traded at around $47.21. The impact to a portfolio due to this purchase was 0.55%. The holding were 1,195,000 shares as of .

Added: MyoKardia Inc (MYOK)

Orbimed Advisors Llc added to a holding in MyoKardia Inc by 170.55%. The purchase prices were between $39.23 and $55.82, with an estimated average price of $46.05. The stock is now traded at around $48.61. The impact to a portfolio due to this purchase was 0.5%. The holding were 906,600 shares as of .

Added: Apellis Pharmaceuticals Inc (APLS)

Orbimed Advisors Llc added to a holding in Apellis Pharmaceuticals Inc by 438.93%. The purchase prices were between $12.81 and $19.82, with an estimated average price of $15.64. The stock is now traded at around $19.35. The impact to a portfolio due to this purchase was 0.47%. The holding were 1,762,300 shares as of .

Sold Out: Allergan PLC (AGN)

Orbimed Advisors Llc sold out a holding in Allergan PLC. The sale prices were between $132.09 and $160.79, with an estimated average price of $144.95.

Sold Out: CVS Health Corp (CVS)

Orbimed Advisors Llc sold out a holding in CVS Health Corp. The sale prices were between $52.36 and $69.88, with an estimated average price of $61.96.

Sold Out: Centene Corp (CNC)

Orbimed Advisors Llc sold out a holding in Centene Corp. The sale prices were between $52.12 and $65.89, with an estimated average price of $60.76.

Sold Out: UnitedHealth Group Inc (UNH)

Orbimed Advisors Llc sold out a holding in UnitedHealth Group Inc. The sale prices were between $236.02 and $271.13, with an estimated average price of $255.35.

Sold Out: bluebird bio Inc (BLUE)

Orbimed Advisors Llc sold out a holding in bluebird bio Inc. The sale prices were between $99.2 and $160.74, with an estimated average price of $135.29.

Sold Out: Molina Healthcare Inc (MOH)

Orbimed Advisors Llc sold out a holding in Molina Healthcare Inc. The sale prices were between $105.9 and $148.29, with an estimated average price of $134.96.



Here is the complete portfolio of ORBIMED ADVISORS LLC. Also check out:

1. ORBIMED ADVISORS LLC's Undervalued Stocks
2. ORBIMED ADVISORS LLC's Top Growth Companies, and
3. ORBIMED ADVISORS LLC's High Yield stocks
4. Stocks that ORBIMED ADVISORS LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK